Ixico sees only 'modest' impact on trading from Covid-19
24th Jun 2020 09:41
(Sharecast News) - Data analytics company Ixico said on Wednesday that Covid-19 had only had a "modest" impact on trading and stated it expects to maintain double-digit revenue growth in 2021.
Read moreIxico in 'robust' position to handle short-term Covid-19 headwinds
20th Apr 2020 08:50
(Sharecast News) - Data analytics firm Ixico said on Monday that it was in a "robust" position to handle short-term headwinds stemming from the Covid-19 pandemic and associated government measures.
Read moreIxico inks ?10.5m contract, trading impacted by Covid-19 in 'multiple ways'
14th Apr 2020 09:32
(Sharecast News) - Neuroscience data analytics firm Ixico has inked a £10.5m contract for a late-phase open-label study into Huntington's disease, but warned that the Covid-19 pandemic had affected it in "multiple ways".
Read moreIxico joins Alzheimer's disease research initiative
3rd Feb 2020 14:05
(Sharecast News) - Artificial intelligence data analytics company Ixico announced funding support for the Alzheimer's Disease Neuroimaging Initiative (ADNI) on Monday, with two of its scientists to join the ADNI-Private Partner Scientific Board (PPSB).
Read moreDirector dealings: Ixico CEO ups stake
23rd Jan 2020 16:10
(Sharecast News) - Ixico revealed on Thursday that chief executive Giulio Cerroni had purchased 24,800 ordinary shares in the British clinical research firm.
Read moreIxico announces extensions to two studies
23rd Dec 2019 15:04
(Sharecast News) - Data analytics company Ixico announced a £1.8m extension to a phase 3 study in Huntington's Disease on Monday, which it had previously announced in September 2018.
Read moreIxico secures three new contracts, appoints chief business officer
28th Oct 2019 13:15
(Sharecast News) - AI data analytics company Ixico said on Monday that it had secured three new contracts and appointed a chief business officer.
Read moreIxico flags better-than-expected performance for full-year
15th Oct 2019 15:33
(Sharecast News) - Artificial intelligence data analytics company Ixico updated the market on its trading for the year ended 30 September on Tuesday, saying it expected its first full year of positive EBITDA since listing.
Read moreIXICO sees full-year results 'materially ahead' of market expectations
19th Aug 2019 09:55
(Sharecast News) - AIM-listed clinical research firm IXICO said on Monday that its annual results will be "materially ahead" of current market expectations following strong revenue growth in the second half.
Read moreIxico revenues on track to meet full-year market expectations
25th Apr 2019 08:35
(Sharecast News) - Data analytics firm Ixico expects half-year revenues to be in line with market expectations.
Read moreIxico signs on two new biopharmaceutical clients
24th Apr 2019 15:53
(Sharecast News) - Data analytics company Ixico has signed contracts with two biopharmaceutical companies to provide its technology-enabled imaging services to support an early phase study in Huntington's disease (HD), and a phase 3 study in another rare neurological disease.
Read moreIxico jumps as new contract wins help to slash losses
4th Dec 2018 08:21
(Sharecast News) - Data analytics outfit Ixico leapt on Tuesday after narrowing its full-year loss and increasing revenue by securing £15m of new and expanded multi-year client contracts.
Read moreNew contract wins of £15m spark revenue growth at Ixico
15th Oct 2018 08:07
(Sharecast News) - Ixico has achieved a 32% increase in annual revenues after expanding the range of medical imaging services that it provides, the company said on Monday.
Read moreIxico surges following contract win with 'top ten' pharma giant
11th Sep 2018 09:06
(Sharecast News) - Ixico has inked a contract with an unnamed pharmaceutical giant to provide its technology-enabled imaging services in support of the firm's pivotal Phase III study into Huntington's disease.
Read moreIXICO agrees upwards change to Alzheimer's contract
30th Aug 2018 14:35
(Sharecast News) - Data science company IXICO has signed a further change order to a current contract, increasing the total contract value to €1.3m, it announced on Thursday.
Read more